The Comparison between ultrasound guided Trans-perineal and Transrectal prostate needle biopsy in the Detection of Prostate Cancer: A prospective randomized study.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202310737952361

Enrollment

Registered

2023-10-19

Start date

2023-09-04

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

Transperineal prostate needle biopsy

TRUS guided Transrectal prostate needle biopsy under local anesthesia

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: • All consenting adult males with positive DRE findings suggestive of PCa and elevated PSA levels > 4ng/ml. • Willingness to sign informed consent and adhere to the study protocol

Exclusion criteria

Exclusion criteria: • Acute prostatitis within the last 6 months. • Current non-urologic bacterial infection requiring active treatment with antibiotics. • Unfit to undergo prostate biopsy under local anaesthesia. • Patients who were uraemic or had uncontrolled hypertension or bleeding diasthesis or patients on anticoagulants or antiplatelets medications. • Prior definitive therapy for prostate cancer, such as radiation therapy or partial gland ablation. • Patients who refused to participate in study.

Design outcomes

Primary

Measure	Time frame
Cancer detection rate	—

Secondary

Measure	Time frame
Pain score and tolerability	—

Countries

Nigeria

Contacts

Public ContactClement AKINSOLA

Researcher

ceefourme@gmail.com2348174226011

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026